Septerna, Inc. (NASDAQ: SEPN) is catching the eyes of investors with its significant potential upside of 123.09%. With a focus on developing groundbreaking G protein-coupled receptor (GPCR) oral small molecule..
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in the diagnostics and research industry, presents an intriguing investment opportunity with a significant potential upside of 42.88%. As investors ponder the financial..
Humacyte, Inc. (NASDAQ: HUMA) is an intriguing player in the biotechnology sector, captivating investor attention with its ambitious pursuit of revolutionizing the medical field. Based in Durham, North Carolina, the..
Verastem, Inc. (NASDAQ: VSTM) stands as a captivating opportunity in the biotechnology sector, capturing the attention of investors with its noteworthy 266.59% potential upside, according to analyst target prices. As..
Oruka Therapeutics, Inc. (NASDAQ: ORKA), a promising player in the biotechnology sector, has caught the attention of investors with its innovative approach in developing monoclonal antibody therapeutics. Headquartered in Menlo..
